Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gang Cai

Showing results (341-350 of 346) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 346 results.
International Journal of Radiation Oncology, Biology, Physics|February 27, 2026
Ultra-hypofractionated whole breast irradiation and sequential tumor bed boost for early breast cancer (SHIFT): primary results of a multicentre, Phase 2 trialSi-Yue Zheng, Jia-Qi Huang, Jin-Rong Xie, et al.
Cancer Communications (London, England)|September 3, 2025
Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trialZhen Zhang, Xinchen Sun, Anwen Liu, et al.
BMJ Open|December 29, 2022
Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trialJinrong Xie, Feifei Xu, Yutian Zhao, et al.
Chinese Journal of Integrative Medicine|January 5, 2026
Andrographolide Sulfonate Injection for Adjunctive Treatment of Non-severe Community-Acquired Pneumonia in Adults: A Multicenter, Double-Blind, Randomized Controlled TrialLian-Han Shang, Guo-Hui Fan, Li-Ping Chen, et al.
Innovation (Cambridge (Mass.))|May 14, 2023
Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III studyHuijuan Zhong, Shu Cheng, Xi Zhang, et al.
Haematologica|April 10, 2025
Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized studyHuijuan Zhong, Shu Cheng, Jie Xiong, et al.
Pageof 35

Showing results (341-350 of 346) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 346 results.
International Journal of Radiation Oncology, Biology, Physics|February 27, 2026
Ultra-hypofractionated whole breast irradiation and sequential tumor bed boost for early breast cancer (SHIFT): primary results of a multicentre, Phase 2 trialSi-Yue Zheng, Jia-Qi Huang, Jin-Rong Xie, et al.
Cancer Communications (London, England)|September 3, 2025
Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trialZhen Zhang, Xinchen Sun, Anwen Liu, et al.
BMJ Open|December 29, 2022
Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trialJinrong Xie, Feifei Xu, Yutian Zhao, et al.
Chinese Journal of Integrative Medicine|January 5, 2026
Andrographolide Sulfonate Injection for Adjunctive Treatment of Non-severe Community-Acquired Pneumonia in Adults: A Multicenter, Double-Blind, Randomized Controlled TrialLian-Han Shang, Guo-Hui Fan, Li-Ping Chen, et al.
Innovation (Cambridge (Mass.))|May 14, 2023
Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III studyHuijuan Zhong, Shu Cheng, Xi Zhang, et al.
Haematologica|April 10, 2025
Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized studyHuijuan Zhong, Shu Cheng, Jie Xiong, et al.
Pageof 35